This paper investigates the correlation between the high level of Severe Acute Respiratory
Syndrome CoronaVirus 2 (SARS-CoV-2) lethality and the atmospheric pollution in Northern …

… Correspondence to Dr Edoardo Conticini, Rheumatology Unit, University of Siena, Siena
53100, Italy; conticini. edoardo@ gmail. com Contributors EC conceived the paper. EC, EB and …

Background While SARS-CoV-2 similarly infects men and women, COVID-19 outcome is less
favorable in men. Variability in COVID-19 severity may be explained by differences in the …

Background: The Coronavirus disease (COVID-19) pandemic is causing millions of infections
and hundreds of thousands of deaths worldwide. Cumulative clinical and laboratory …

Background Baricitinib is a JAK inhibitor that blocks intracellular signalling pathways of
inflammatory cytokines recommended for Rheumatoid arthritis (RA) patients not responding to …

Clinical and molecular characterization by Whole Exome Sequencing (WES) is reported in
35 COVID-19 patients attending the University Hospital in Siena, Italy, from April 7 to May 7, …

Objective The main objective of this study was to analyse the prevalence and characteristics
of subclinical GCA in patients with PMR. Methods This was a cross-sectional multicentre …

Objective: The aim of this paper is to present the AutoInflammatory Disease Alliance (AIDA)
international Registry dedicated to Vacuoles, E1 enzyme, X-linked, Autoinflammatory, …

Vasculitis are severe systemic autoimmune diseases which may involve different organs and
systems. Conversely, muscles do not represent an organ commonly involved by systemic …

Objectives Baricitinib, an oral Janus kinase (JAK) 1-2 inhibitor, is currently used along biologic
DMARDs (bDMARDs) after the failure of methotrexate (MTX) in rheumatoid arthritis (RA). …